Literature DB >> 1311984

Ovarian mucinous tumors frequently express markers of gastric, intestinal, and pancreatobiliary epithelial cells.

P Tenti1, A Aguzzi, C Riva, L Usellini, R Zappatore, J Bara, I M Samloff, E Solcia.   

Abstract

In 100 mucinous tumors of the ovary (37 benign, 24 borderline, and 39 malignant), the authors determined by histochemical and immunohistochemical techniques the frequencies and patterns of expression of a total of nine markers of gastric, intestinal, and pancreatobiliary duct epithelial cells. M1, a mucin antigen, and cathepsin E (CaE), an aspartic proteinase, two markers of normal gastric superficial/foveolar epithelial cells, were expressed in 95 and 92 tumors, respectively. Periodic acid-concanavalin A-reactive mucin or pepsinogen (PG) II, markers of gastric mucus neck and pyloric gland cells, were found in 79 tumors. All of these tumors also expressed M1 or CaE. DU-PAN-2 and the N-terminal epitope of gastrin-releasing peptide, markers of normal pancreatobiliary duct cells, were found in 70 and 49 tumors, respectively, and CAR-5 and M3SI, markers of intestinal mucin, were expressed in 51 and 30 tumors, respectively. All tumors expressed at least two of the nine markers studied; none expressed PG I, a marker of gastric chief cells. The mucopeptic cell marker, PG II, was significantly more common in benign and borderline than in malignant tumors (P less than 0.005), whereas CAR-5 and M3SI, markers of intestinal mucin, were expressed significantly more often in malignant than in benign and borderline tumors (P less than 0.001). By electron microscopic examination, many tumor cells had fine structural features characteristic of gastric superficial/foveolar and pyloric gland cells, intestinal columnar or goblet cells, and endocervical cells. The results indicate that gastroenteropancreatic cell differentiation--and, in particular, gastric type differentiation--is a prominent feature of ovarian mucinous tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311984     DOI: 10.1002/1097-0142(19920415)69:8<2131::aid-cncr2820690820>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Simultaneous mucinous cystadenoma of ovary and mucinous cystadenocarcinoma of pancreas.

Authors:  L J Gagne; T Colacchio; D S Longnecker
Journal:  Int J Pancreatol       Date:  2000-08

2.  Primary retroperitoneal mucinous cystoadenocarcinomas: an immunohistochemical and molecular study.

Authors:  P Tenti; S Romagnoli; N S Pellegata; R Zappatore; P Giunta; G N Ranzani; L Carnevali
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 3.  Primary mucinous cystadenocarcinoma of the retroperitoneum. Report of a case and literature review.

Authors:  E Carabias; H Garcia Muñoz; F P Dihmes; M A López Pino; C Ballestín
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 4.  Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.

Authors:  Corbin Pontious; Sabrina Kaul; Marcus Hong; Phil A Hart; Somashekar G Krishna; Luis F Lara; Darwin L Conwell; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2019-09-20       Impact factor: 3.996

Review 5.  Recent concepts of ovarian carcinogenesis: type I and type II.

Authors:  Masafumi Koshiyama; Noriomi Matsumura; Ikuo Konishi
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

Review 6.  Pepsinogen C expression, regulation and its relationship with cancer.

Authors:  Shixuan Shen; Jingyi Jiang; Yuan Yuan
Journal:  Cancer Cell Int       Date:  2017-05-23       Impact factor: 5.722

Review 7.  Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma.

Authors:  Borbála Kiss; Edit Mikó; Éva Sebő; Judit Toth; Gyula Ujlaki; Judit Szabó; Karen Uray; Péter Bai; Péter Árkosy
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

Review 8.  Ovarian cancer: pathology, biology, and disease models.

Authors:  Daniel G Rosen; Gong Yang; Guangzhi Liu; Imelda Mercado-Uribe; Bin Chang; Xue Sherry Xiao; Jingfang Zheng; Feng-Xia Xue; Jinsong Liu
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

9.  A synchronous presentation of two different ovarian tumors: a rare occurrence.

Authors:  D Sethi; C Ahluvalia; U Sharma; S Khetarpal
Journal:  Ann Med Health Sci Res       Date:  2013-04

10.  Bilateral ovarian masses with different histopathology in each ovary.

Authors:  Saeed Baradwan; Haneen Alalyani; Amira Baradwan; Afnan Baradwan; Maram Al-Ghamdi; Jameel Alnemari; Dania Al-Jaroudi
Journal:  Clin Case Rep       Date:  2018-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.